Latest Corporate news updates; Pharma Feb 3rd 2022... Feb 03
Latest corporate news update : Pharma Jan 1/2022... Feb 01
Latest pharma news update... Aug 02
New solutions are needed for the six million people in the US affected by anaemia of chronic kidney disease.... Jul 17
If approved, Forxiga has the potential to change the treatment paradigm for millions of people in the EU suffering from chronic kidney disease... Jun 28
... Jun 25
Recommendation based on positive results from the Phase 3 CheckMate -577 trial in which Opdivo doubled disease-free survival compared to placebo in the all-... Jun 25
GSK's Covid product could be soon in the market after the emergency medical application review... May 11
COMIRNATY will be produced in BioNTech’s and Pfizer’s manufacturing sites in Europe ... Apr 20
Ogluo (Glucagon) is indicated treatment of severe hypoglycemia... Feb 15
New option extends dosing from two to four weeks, reducing medical visits and improving patient convenience ... Jan 15
This new dosing option is consistent with the approved Imfinzi dosing in extensive-stage small cell lung cancer and once approved, will be available to ... Dec 15
Shorter infusion time will further improve the twice-yearly treatment experience for OCREVUS, the only B-cell therapy for relapsing and primary progressive MS with ... Dec 15
The impact of the disease is significant, with breast cancer responsible for more than 137,000 deaths per year.... Dec 14
COPD is a progressive disease, which can cause obstruction of airflow in the lungs resulting in debilitating bouts of breathlessness and is the third leading ... Dec 14
Biocon subsidiary Mylan advances their ... Dec 14
CHMP issues positive opinion for use of Plavix with aspirin in adults within 24 hours of minor ischemic stroke or high-risk transient ischemic attack ... Dec 12
This year US FDA has approved BAVENCIO for the maintenance treatment of patients with locally advanced or metastatic UC... Dec 12
Dynavax Technologies Corporation, today announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion on ... Dec 11
If approved, Inrebic will become the first new therapy for myelofibrosis in Europe in nearly a decade.... Dec 11
... Dec 11
Fostemsavir addresses a critical unmet need in HIV care for those with little to no treatment options left.... Dec 11
The company believes that OTL-200 offers tremendous potential to transform the lives of many young patients with MLD... Nov 21
Dolutegravir is the first integrase inhibitor available as a dispersible tablet for children... Nov 13
European Commission approves Roche’s Tecentriq in combination with Avastin for the treatment of people with the most common form of liver cancer.... Nov 02
-Advertisements-
.jpeg)
Monday, October 05, 2026
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpeg)
.jpeg)
.png)